Oral icotrokinra is now FDA-approved for plaque psoriasis, offering a new systemic option for adults and adolescents who weigh at least 40kg.

Scientists are making rapid progress toward a long-awaited goal that could help to reshape cancer care: mRNA cancer vaccines with the potential ...

Significantly more patients had no chemotherapy-induced thrombocytopenia-induced modification of chemo dose with romiplostim vs placebo.

Eleven point four percent of adults aged 65 to 79 years with stage 1 hypertension would not be eligible under 2025 criteria.

The FDA awards Fast Track designation to BW-20805 for hereditary angioedema, a therapy designed to reduce attacks through PKK ...

Previously, the Company had received CRLs in November 2023 and April 2025 due to insufficient evidence in addressing the ...

A federal judge stays all votes by the restructured CDC vaccine panel, ruling that recent appointments likely violate the Federal Advisory Committee Act.

Vaccine effectiveness was 38 to 41 percent against influenza outpatient visits, 41 percent against flu-linked hospitalization for children younger than 18 years ...

Researchers found that all-cause mortality was significantly lower in association with GLP-1 RA use. HealthDay News — For patients with cancer and brain metastases (BM) and type 2 diabetes (T2D), ...

Overall, 5.7 percent of participants with MCI had one-year risk for any indication for anticoagulant and thrombolytic drugs ...

HealthDay News — Digital media use is consistently associated with risks to child and adolescent mental health and development globally, according to a review published online March 9 in JAMA ...

Findings from the FIND-CKD trial indicate finerenone may provide a new treatment option for slowing renal function loss in CKD patients without diabetes.